MedPath

AXIRON

AXIRON

Discontinued
DIN Number

02382369

Drug Class

Human

Market Date

May 8, 2013

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02382369
AIG Number0106405011
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA03 TESTOSTERONE
Product Specifications
Dosage FormSolution
Route of AdministrationTransdermal
AHFS Classification68:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TESTOSTERONEActive
Strength: 30 MG / ACT
Monograph: TESTOSTERONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.